Literatur
1.
Neuhauser H, Diederichs C, Boeing H, et al: Bluthochdruck in Deutschland. Daten aus sieben bevölkerungsbasierten epidemiologischen Studien (1994-2012). Dtsch Arztebl 2016;113:809-815.
2.
Houston M: Nutrition and nutraceutical supplements for the treatment of hypertension: part I. J Clin Hypertens (Greenwich) 2013;15:752-757.
3.
Houston M: Nutrition and nutraceutical supplements for the treatment of hypertension: part II. J Clin Hypertens (Greenwich) 2013;15:845-851.
4.
Houston M: Nutrition and nutraceutical supplements for the treatment of hypertension: part III. J Clin Hypertens (Greenwich) 2013;15:931-937.
5.
Lameris AL, Monnens LA, Bindels RJ, Hoenderop JGJ: Drug-induced alterations in Mg2+ homoeostasis. Clin Sci (Lond) 2012;123:1-14.
6.
Graudal N, Jürgens G, Baslund B, Alderman MH: Compared with usual sodium intake, low and excessive sodium diets are associated with increased mortality. A meta-analysis. Am J Hypertens 2014;27:1129-1137.
7.
Cappuccio FP, Markandu ND, Carney C, Sagnella GA, MacGregor GA: Double-blind randomized trial of modest salt restriction in older people. Lancet 1997;350:850-854.
8.
He FJ, MacGregor GA: How far should salt intake be reduced? Hypertension 2003;42:1093-1099.
9.
Zidek W: Kochsalz und Hypertonie. Cardiovasc 2013;1:49-50.
10.
He FJ, Li J, Macgregor GA: Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ 2013;346:f1325.
11.
Houston M: The role of magnesium in hypertension and cardiovascular disease. J Clin Hypertens (Greenwich) 2011;13:843-847.
12.
Poorolajal J, Zeraati F, Soltanian AR, Sheikh V, Hooshmand E, Maleki A: Oral potassium supplementation for management of essential hypertension: a meta-analysis of randomized controlled trials. PLoS One 2017;12:e0174967.
13.
Whelton SP, Blumenthal RS: Beyond the headlines: insights on potassium supplementation for the treatment of hypertension from the Canadian Hypertension Education Program guidelines (CHEP). Circulation 2017;135:3-4.
14.
Zhang X, Li Y, Del Gobbo LC, Rosanoff A, Wang J, Zhang W, Song Y: Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials. Hypertension 2016;68:324-333.
15.
Kisters K, Gremmler B, Gröber U, Tokmak F: Magnesium metabolism, vitamin D and interleukins in cardiovascular disease. Metabolomics 2016,6:177.
16.
Guerrero-Romero F, Rodríguez-Morán M, Hernández-Ronquillo G, et al: Low serum magnesium levels and its association with high blood pressure in children. J Pediatr 2016;168:93-98.e1.
17.
Rosanoff A: Magnesium supplements may enhance the effect of antihypertensive medication in stage 1 hypertensive subjects. Magnes Res 2010;23:27-40.
18.
Kienreich K, Tomaschitz A, Verheyen N, Pieber TR, Pilz S: Vitamin D and arterial hypertension: treat the deficiency! Am J Hypertens 2013;26:158.
19.
Belen E, Sahin I, Güngör B, et al: Assessment of 25-hydroxyvitamin D levels in patients with resistant hypertension. Med Princ Pract 2016;25:25-30.
20.
Arora P, Song Y, Dusek J, et al: Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial. Circulation 2015;131:254-262.
21.
Pilz S, Gaksch M, Kienreich K, et al: Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial. Hypertension 2015;65:1195-1201.
22.
Tamez H, Kalim S, Thadhani RI: Does vitamin D modulate blood pressure? Curr Opin Nephrol Hypertens 2013;22:204-209.
23.
Qi D, Nie X, Cai J: The effect of vitamin D supplementation on hypertension in non-CKD populations: a systemic review and meta-analysis. Int J Cardiol 2017;227:177-186.
24.
Al Mheid I, Quyyumi AA: Vitamin D and cardiovascular disease: controversy unresolved. J Am Coll Cardiol 2017;70:89-100.
25.
Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C: Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2014;(1):CD007470.
26.
Holick MF, Binkley NC, Bischiff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM; Endocrine Society: Evaluation, treatment and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911-1930.
27.
van Ballegooijen AJ, Cepelis A, Visser M, Brouwer IA, van Schoor NM, Beulens JW: Joint association of low vitamin D and vitamin K status with blood pressure and hypertension. Hypertension 2017;69:1165-1172.
28.
Shea MK, Booth SL, Weiner DE, Brinkley TE, Kanaya AM, Murphy RA, Simonsick EM, Wassel CL, Vermeer C, Kritchevsky SB; Health ABC Study: Circulating vitamin K is inversely associated with incident cardiovascular disease risk among those treated for hypertension in the Health, Aging, and Body Composition Study (Health ABC). J Nutr 2017;147:888-895.
29.
Serban MC, Sahebkar A, Zanchetti A, Mikhailidis DP, Howard G, Antal D, Andrica F, Ahmed A, Aronow WS, Muntner P, Lip GY, Graham I, Wong N, Rysz J, Banach M; Lipid and Blood Pressure Meta‐analysis Collaboration (LBPMC) Group: Effects of quercetin on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 2016;5:e002713.
30.
Biesinger S, Michaels HA, Quadros AS, Qian Y, Rabovsky AB, Badger RS, Jalili T: A combination of isolated phytochemicals and botanical extracts lowers diastolic blood pressure in a randomized controlled trial of hypertensive subjects. Eur J Clin Nutr 2016;70:10-16.
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or...
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.